Beta-lactamase variants
    2.
    发明授权

    公开(公告)号:US10982205B2

    公开(公告)日:2021-04-20

    申请号:US16078040

    申请日:2017-02-22

    Abstract: The present invention relates to an isolated polypeptide having beta-lactamase activity and nucleic acid sequences encoding the polypeptide. The isolated polypeptide of the invention is a Verona integron-encoded metallo-β-lactamase (VIM-2) variant with improved properties such as improved protease stability, stability in intestinal medium, improved activity against one or more antibiotics, improved specific activity and/or improved production in a host cell.

    BETA-LACTAMASE VARIANTS
    3.
    发明申请

    公开(公告)号:US20200318094A1

    公开(公告)日:2020-10-08

    申请号:US16757968

    申请日:2018-10-24

    Abstract: The present invention relates to an isolated polypeptide having beta-lactamase activity and nucleic acid sequences encoding the polypeptide. The isolated polypeptide of the invention is a VIM-2 variant with improved properties such as improved protease stability, stability in intestinal medium, improved activity against one or more antibiotics, improved specific activity and/or improved production in a host cell.

    BETA-LACTAMASE VARIANTS
    4.
    发明申请

    公开(公告)号:US20220356459A1

    公开(公告)日:2022-11-10

    申请号:US17745205

    申请日:2022-05-16

    Abstract: The present invention relates to an isolated polypeptide having beta-lactamase activity and nucleic acid sequences encoding the polypeptide. The isolated polypeptide of the invention is a VIM-2 variant with improved properties such as improved protease stability, stability in intestinal medium, improved activity against one or more antibiotics, improved specific activity and/or improved production in a host cell.

Patent Agency Ranking